Stay updated on Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial

Sign up to get notified when there's something new on the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The Locations section was updated to add numerous new sites across the United States, Argentina, Australia, Chile, and other countries, while many existing sites were removed. This changes which sites are available for participant enrollment and may affect recruitment timelines.
    Difference
    3%
    Check dated 2025-12-23T13:36:14.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.2.0 was removed, appearing as metadata on the page, and these updates do not modify the study details or any user-facing content (To avoid being alerted by small changes, set an alert condition by clicking below).
    Difference
    0.2%
    Check dated 2025-11-24T17:05:51.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Location entries updated: Tainan City entries for site 704 and 710 were replaced with 'Tainan, Taiwan, 704' and 'Tainan, Taiwan, 710', and the two new Taiwan sites were added. A government funding status notice was removed.
    Difference
    0.2%
    Check dated 2025-11-17T15:04:16.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Added the labels 'Results First Posted (Estimated)' and 'Last Update Posted (Estimated)' in the Study Record Dates; removed the non-estimated 'Results First Posted' and 'Last Update Posted' entries.
    Difference
    0.2%
    Check dated 2025-11-03T01:30:41.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Results have been posted with detailed efficacy and patient-reported outcome measures (e.g., ACR 20 at Week 16, PASI, HAQ-DI, DAS28-CRP, SF-36, PsAID, DAPSA, PsARC, BASDAI, SvdH, etc.). The Cali, Colombia site entry was updated to indicate Cali (760042), replacing the previous Santiago de Cali listing.
    Difference
    4%
    Check dated 2025-10-26T20:52:16.000Z thumbnail image
  9. Check
    88 days ago
    Change Detected
    Summary
    The page updates to v3.2.0 and adds a government funding operating-status notice, replacing the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T10:34:18.000Z thumbnail image

Stay in the know with updates to Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page.